Advanced Media, Inc.
3773・Growth Market・Information & Communication
Business
Advanced Media, Inc. is a voice AI specialist company that pursues the vision of "Realizing HCI (Human Communication Integration)" and develops products and services centered on its proprietary AI speech recognition engine "AmiVoice®." The company is organized into eight profit units, with four divisions—contact centers (CTI Division), assemblies/meetings (VoXT Division), healthcare (Medical Division), and API/manufacturing & logistics (SDX Division)—forming BSR1 (the first growth engine), and construction/real estate (BDC Headquarters), overseas operations, and consolidated subsidiaries forming BSR2 (the second growth engine). The company has a track record of adoption across a wide range of industries, including 20,032 medical facilities, 610 call centers, and 578 construction/real estate companies, and posted record-high net sales of ¥7,063 million in FY2026 (ending March 2026).
Business Model
Revenue is generated through three business formats: the Service Business (cloud-based subscription), Product Business (license sales), and Solution Business (contracted development). Expansion of recurring revenue is being promoted across all BSR1 business divisions, and the BSR1 recurring revenue ratio reached 80.0% (+5.4pt YoY) at the end of FY2026 (ending March 2026). Indirect sales through partnerships with major SIers and sales partners are also being leveraged, achieving both expansion of the customer base and stable revenue through continued billing.
Company Strengths
The company has installation track records at 20,032 medical facilities equipped with medical terminology-compliant engines, 610 contact center companies, 578 construction/real estate companies, and 3,176 parliamentary/municipal facilities. Its industry-optimized speech recognition engines and product lineup form entry barriers that are difficult for competitors to replicate in a short period, and the company ranked No. 1 in the speech recognition software/cloud service market according to a survey by ecarlate LLC (April 2026).
Recurring revenue for BSR1 overall reached ¥4,973 million (up 12.2% year on year), with the recurring revenue ratio reaching 80.0% (up 5.4 points year on year). Subscription adoption is progressing across business divisions, with the CTI Division at 82.9%, the VoXT Division at 96.7%, and the SDX Division at 76.2%, achieving a revenue structure that is relatively stable against economic fluctuations.
As of the end of FY2026 (ending March 2026), the equity ratio stood at 84.2% (improved from 77.1% in the previous fiscal year), and cash and cash equivalents totaled ¥5,489 million. Repayment of long-term borrowings progressed, compressing total liabilities to ¥2,635 million. Operating cash flow was stably generated at ¥1,853 million, giving the company the financial capacity to fund M&A and upfront investments from its own resources.
ENVALITH's Perspective
Performance Trend
Revenue rose from ¥4,461 million in FY2022 (ended March 2022) to ¥7,063 million in FY2026 (ending March 2026), marking a fifth consecutive year of revenue growth and a new record high (up 6.0% year on year). On the other hand, operating profit stood at ¥1,440 million in FY2026 (ending March 2026), down slightly by 0.2% year on year, turning to a decline, and the operating profit margin fell from 21.6% to 20.4%. This was due to an increase in cost of sales and expanded upfront investment in personnel and development. Ordinary profit reached a record high of ¥1,558 million (up 1.2% year on year), driven by an increase in interest income (an external factor reflecting rising interest rates) and an increase in foreign exchange gains (an external factor reflecting yen depreciation). Net income attributable to owners of parent reached a record high of ¥1,739 million (up 23.5% year on year), reflecting the recognition of ¥997 million in gain on sale of investment securities. Recurring (stock-type) revenue was ¥4,973 million (up 12.2% year on year), with the recurring revenue ratio reaching 80.0%, indicating steady improvement in the quality of earnings.
Growth Strategy
Targeting revenue of ¥10,000 million and operating profit of ¥1,500 million in the final year of the BSR Growth Phase, while cultivating the AISH market
The initial operating profit target of ¥2.5 billion has been revised down to ¥1.5 billion, reflecting changes in the revenue structure resulting from M&A, rising costs, and the impact of upfront investments. For FY2027 (ending March 2027), on an IFRS basis, the company forecasts revenue of ¥10,000 million, operating profit of ¥1,500 million, and profit attributable to owners of the parent of ¥1,100 million.
The company is promoting sales channel development and expansion for AISH products and services through partnerships with other companies, including M&A. In April 2026, feat inc. was made a wholly owned subsidiary, incorporating its development capabilities and personnel with a view to creating composite solutions as a "Voice AI Enabler."
The CTI, VoXT, Medical, and SDX business divisions are continuously building up license counts, improving the stock revenue ratio. At the end of FY2026 (ending March 2026), the BSR1 stock revenue ratio reached 80.0% (up 5.4 percentage points year on year), with stock revenue of ¥4,973 million (up 12.2% year on year).
By expanding sales channels and sales of the AI aggregation model (SAM) and AWB (AISH Work Basis), which combine generative AI and AI agents (GAI) with the company's proprietary PAI (Personalized AI), the company aims to build a foundation for the next three-year period (AISH Deployment and Expansion Phase).
With the aim of improving the international comparability of financial information in the capital markets, the company will voluntarily adopt IFRS from the first quarter of FY2027 (ending March 2027), aiming to strengthen its appeal to global investors and improve capital efficiency.
Last updated: July 19, 2026